Jump to content

s4rx7

Member
  • Posts

    1836
  • Joined

  • Last visited

Everything posted by s4rx7

  1. s4rx7

    RRS

    Hi everyone, still here, patiently waiting, this stock reminds me of KAR, but with so many twists and turns along the way. Finally the rewards are starting to show..........the long termers need more than caps, we need medals!! Have no clue where it will end up but I plan to stay the distance, that's if I live long enough! Anyway, I send a wave to all the friends I have made over the years on sharescene
  2. s4rx7

    PVA

    Well in my opinion its time to Buy PSD There, that shocked you!! http://www.sharescene.com/html/emoticons/tongue.gif Looking much better than anytime in the last 18 months from what i can see.
  3. s4rx7

    PVA

    QUOTE (astoria @ Wednesday 13/06/07 08:26am) "This could see a party end up with 200mil shares in PSD and PSD getting about 32mil from the conversion of these warrants." Now who would want to do that? looks like a Pfizer footprint , are we happy yet ?
  4. s4rx7

    PVA

    In reply to: s4rx7 on Tuesday 12/06/07 03:52pm http://www.secinfo.com/d12TC3.uUyd.htm#5q3l
  5. s4rx7

    PVA

    PSIVIDA LTD Files SEC form 424B3, Prospectus filed pursuant to Rule 424(b)(3)
  6. s4rx7

    RRS

    This year......... easy http://www.sharescene.com/html/emoticons/graduated.gif
  7. s4rx7

    RRS

    RRS will in my opinion , be going a lot Higher than anyone expects. Its a 10 bagger minimum for the funds, probably a 30 bagger,maybe even more. There seems to be a lot of excitement today, but I believe that there is so much more to come. I will get excited @$6 http://www.sharescene.com/html/emoticons/lmaosmiley.gifhttp://www.sharescene.com/html/emoticons/lmaosmiley.gifhttp://www.sharescene.com/html/emoticons/lmaosmiley.gif RANGEHHHHHHOOOOOOOOOOOOOOOOOOOO
  8. s4rx7

    RRS

    Well, 2 years ago I thought Range was the next Paladin PDN, now I am convinced it is. Rangehooooooo http://www.sharescene.com/html/emoticons/weirdsmiley.gif
  9. s4rx7

    RRS

    Range Valued at $7 per share!! http://www.sharescene.com/html/emoticons/tongue.gif I think that may cause a run,dont you? Consort completed. The Sell side has been stripped by the opening volume, deep pockets at work here. Announcement out about Independant research report........Values the stock at $7 Lloyd Edwards-Jones Research Note Lloyd Edwards-Jones has made an attempt to value the Range Resources stock. Cautiously assuming a constant crude price of US$ 40/bl and a 10% discount rate whilst adopting the "most likely" geological scenario resulting from Conoco's work as endorsed by Range, we arrive, at this pre-exploration stage, at a post-consolidation (1 for 20) fair value of AUS$ 7.00 per share. I think we have a run coming. http://www.sharescene.com/html/emoticons/lmaosmiley.gif
  10. s4rx7

    RRS

    re Toscafund 5-12-2006 LONDON (AFX) - Former Royal Bank of Scotland Group PLC chairman Sir George Mathewson has been appointed chairman of hedge fund Toscafund Holdings Ltd. In a statement, London-based Toscafund said Mathewson will provide the company 'with oversight and guidance on its development and growth.' He takes up his post with immediate effect. 'I am extremely pleased that Sir George has accepted our offer to become chairman. To have someone of his calibre on the board is an enormous asset to Toscafund,' Toscafund chief executive Martin Hughes said. Mathewson served as chairman of RBS, the UK's second-biggest bank, from 2001 until April this year. He had previously held the role of RBS chief executive between 1992 and 1999. Toscafund is a global equity hedge fund with 4 bln usd under management.
  11. s4rx7

    RRS

    Speeding ticket http://www.sharescene.com/html/emoticons/tongue.gif Indicative opening looks good @67
  12. s4rx7

    RRS

    Why?? They didn't deem it necessary on the way down http://www.sharescene.com/html/emoticons/tongue.gif Where to now?
  13. s4rx7

    PVA

    Slithering on in By the looks of it....... shareprice will be slaughtered Takeover is in motion....... shareholders will have to average down to get a return. Any objections to that scenario?? Dont bother chooka, you are hopeless at battleships. http://www.sharescene.com/html/emoticons/biggrin.gif
  14. s4rx7

    PVA

    Unfortunately There is your last sell signal IMOP The pump and dump looks orchestrated Whats left? No director would leave a company bound for success in the way thats been mooted. Next stop ?????? Suspension seems likely. But then again, Pfizer wants it ,...............doesnt it????!!! Bring back Astoria and pump the guts one more time. Sorry for you misery.
  15. s4rx7

    RRS

    Game over http://www.sharescene.com/html/emoticons/lmaosmiley.gif
  16. s4rx7

    PVA

    Lets find out about GEM Global Yield Fund. http://www.sharescene.com/html/emoticons/biggrin.gif
  17. s4rx7

    PVA

    pSivida sells AION diagnostics to GEM Global Yield Fund, a portfolio management company for US 3 million. Another one bites the dust. pSivida_Sells_AION_Diagnostics_Subsidiary.pdf
  18. s4rx7

    PVA

    QUOTE (astoria @ Thursday 12/04/07 12:05pm) Astoria Come clean where do you work? the Bell tolls, and you are on shaky ground. Lets take a vote.........who believes anything Astoria says.
  19. s4rx7

    PVA

    Thanks motorway, beautifully put. This post, along with motorways theme, appears to me to sum up the current situation as I see it. Post Subject: re: PSD - PSDV back on Reg Sho List again...... Posted By: lookingconfident Board: PSD (GOTO MAIN) Posted On: 10/04/2007 2:41:07 PM In reply to: 7179 Poster IP: xxx.xxx.xxx.xxx Post: 7180 + Reply To Post - Back To Board > Email To A Friend < Previous Post > Next Post < will PSD ever be a winner under these circumstances > Absolutely! But patience will be required. The stock appears to be presenting some great arbitrary opportunities for the "powers to be" ATM (THAT'S the buying of shares in one market and selling them in another) with last night's close in the US (with volume of 261,856), said to be an "equivalent" of just .19cps, supporting my suggestion. I've been "well schooled" with LOK (Looksmart) on this matter (some 1 million shares have been bought here & sold in the US over the past 12 months) and have decided to forgo the 'pain & suffering' associated with such practices, particularly as Looksmart appear to be getting a lot closer these days. Hold and add where it becomes rediculously lower, (is now there, many would feel), and maybe 'trade' the peaks, based on what's happening in the US and Germany, provided reasonable volume remains with both of them. It could be a 'roller coaster' ride for a while. A winner in the long term, is my belief. (last trade .2450c) cheers.
  20. s4rx7

    PVA

    I like your posts motorway but you appear to be a fence sitter. Is PSD a BUY or a SELL? is the smart money buying or selling? I understand only too well that everyone has their own timeframe, and ones opinion is clearly affected by that. But, logic tells me PSD is struggling on all fronts that matter to any holder. The short term smart money appears to have exited this run. So we await the next cycle ?? or go elsewhere for the next mover. Good On you Pess, I like your consistency http://www.sharescene.com/html/emoticons/tongue.gif If for no other reason Pess should get some kind of reward as a stayer. Ok thats all from me, cheers and good luck to all the genuine investors.
  21. s4rx7

    RRS

    http://www.sharescene.com/html/emoticons/biggrin.gifhttp://www.sharescene.com/html/emoticons/biggrin.gif s4 back for the party.........I saw the LIGHT!!!! and and it was GAY that week so i had to turn back....... weirdness week returns..check your stars. and and and the oppies will be all good IMHOP
  22. s4rx7

    PVA

    Subsequent events to my last post, shareprice close as at 13/10/2006 = 31.5 CENTS. todays close = TWENTY TWO point FIVE CENTS. thats progress for you Date Time Info Headline Pages 11/04/2007 09:29 Section 708A Notice 1 10/04/2007 18:08 Appendix 3B 8 10/04/2007 09:56 Provides Further Information on A$11m Placement 2 05/04/2007 14:07 Section 708A Notice 1 05/04/2007 09:29 pSivida announces A$11million private placement 2 04/04/2007 11:11 Signs $203m Licensing Deal with Pfizer 2 04/04/2007 09:51 pSivida redeems Sandell Convertible Note 2 02/04/2007 09:52 Trading Halt 2 29/03/2007 15:21 Response to ASX Share Price Query 4 02/03/2007 09:05 Standard and Poors Announces March Quarterly Rebalance 5 28/02/2007 18:15 Half Yearly Report & Half Year Accounts 23 22/02/2007 18:29 Section 708A 1 22/02/2007 18:22 Appendix 3B 8 20/02/2007 18:33 Results of General Meeting 4 19/02/2007 09:38 A$11.5m (US$9m) Placement 1 31/01/2007 18:41 Commentary - 31 December 2006 Quarterly Cash Flow 4 31/01/2007 18:34 Commitments Test Entity - Second Quarter Report 5 30/01/2007 09:41 Retisert given streamlined Medicare reimbursement 2 29/01/2007 18:14 Final Director's Interest Notice 2 24/01/2007 09:28 Appoints Boston based Managing Director 2 23/01/2007 16:48 Notice of General Meeting 21 16/01/2007 18:44 Initial Director's Interest Notice 2 09/01/2007 10:06 Signs drug delivery licensing agreement with Faber 3 04/01/2007 16:11 Section 708A Notice 1 04/01/2007 16:04 Appendix 3B 8 02/01/2007 14:46 Released from Loan Covenant 2 27/12/2006 09:34 Enters licensing negotiations with Big Pharma 2 20/12/2006 12:07 Completes $3.7m Placement 2 20/12/2006 12:07 Reinstatement to Official Quotation 1 19/12/2006 10:48 Suspension from Official Quotation 2 15/12/2006 13:01 Trading Halt 1 27/11/2006 20:02 S.708A Notice 1 21/11/2006 16:57 Appendix 3B 8 20/11/2006 09:21 Transdermal Drug Delivery Program 2 15/11/2006 17:58 Appendix 3B 8 15/11/2006 17:51 Results of AGM 2 13/11/2006 10:08 Signs MOU with Nordic Biotech for $33.7m 3 10/11/2006 11:37 Section 708A Notice 1 10/11/2006 10:09 In Negotiation with biotech fund for $A33.7M investment 2 09/11/2006 19:20 Appendix 3B 8 01/11/2006 08:31 Quarterly Report Commentary & Highlights 5 31/10/2006 20:15 Appendix 3B 8 31/10/2006 20:13 Commitments Test Entity - First Quarter Report 5 13/10/2006 18:01 Notice of Annual General Meeting 8 10/10/2006 08:29 First Patient Implanted in European Pancreatic Cancer Study 2 29/09/2006 20:28 2006 Annual Report 103 27/09/2006 10:41 Completes Agreement to Secure Additional US$6.5m Funding 11 27/09/2006 10:38 Voluntary Lock-up Period Expires on Acquisition Shares 2 26/09/2006 18:37 Non-Executive Director Appointment 2 19/09/2006 18:55 Results of General Meeting 3 19/09/2006 12:34 Initiation of Phase II clinical study of new product 2 15/09/2006 10:44 Completes agreement with existing Note Holder 2 14/09/2006 08:29 Preliminary Final Report 17 13/09/2006 09:23 Retisert wins International Award 2 28/08/2006 17:56 Final Director's Interest Notice 2 28/08/2006 09:34 Non-exec Director resigns from Board 2 21/08/2006 18:15 Notice of Extraordinary General Meeting 18 31/07/2006 19:11 Final Director's Interest Notice 2 31/07/2006 09:57 Secures additional US$6.5m funding 2 31/07/2006 09:56 pSivida Management Changes 2 31/07/2006 09:52 Commentary re: Quarterly Report 6 31/07/2006 09:48 Commitments Test Entity - Fourth Quarter Report 5 17/07/2006 09:30 Amends subordinated convertible debentures 4 10/07/2006 17:42 To present at the NanoEquity Europe 2006 Conference 2 05/07/2006 09:41 BioSilicon Demonstrates Adjuvant Properties 2 30/06/2006 17:58 Voluntary Lock-Up Period Expires on Acquisition Shares 2 22/06/2006 16:51 pSivida to present at the London Biotech Investment Forum 2 14/06/2006 15:48 pSivida to present at the Wall Street Analyst Forum 2 14/06/2006 09:52 pSivida Rights Issue Closure 2 14/06/2006 09:38 Change of Director's Interest Notice 2 14/06/2006 09:37 Change of Director's Interest Notice 2 14/06/2006 09:37 Change of Director's Interest Notice 2 08/06/2006 09:56 BioSilicon Breakthrough 3 07/06/2006 09:54 Govt Approvals for International Phase 3 trials for Medidur 3 30/05/2006 14:29 Directors to take up Entitlements under the Rights Issue 2 30/05/2006 09:59 BrachySil Regulatory Approval for European Pancreatic Trial 2 25/05/2006 10:06 Expansion of BrachySil Liver Cancer Clinical Trial 2 24/05/2006 14:10 Despatch of Rights Issue Prospectus 2 23/05/2006 10:14 Appoints Boston Based CFO & General Counsel 2 11/05/2006 18:30 Prospectus for a Non-renounceable Rights Offer 69 02/05/2006 14:08 Appendix 3B Rights Issue 11 02/05/2006 13:39 Rights Issue to fund late stage Macular Edema trials 3 28/04/2006 13:54 Appendix 4C - Commentary & Highlights 4 28/04/2006 13:43 Commitments Test Entity - Third Quarter Report 5 21/04/2006 16:14 Appendix 3B - Exercise of Unlisted Options 7 21/04/2006 09:51 To present at UBS Conference in New York 2 06/04/2006 09:50 Positive European Trial Results for Retisert 2 05/04/2006 09:29 New evaluation agmt for cardiovascular drug delivery 2 03/04/2006 09:47 Retisert slows progression of Diabetic Retinopathy in trials 3 22/03/2006 09:36 Open Briefing: pSivida Update on Progress 6 21/03/2006 09:52 DSMB Recommends Continuation of Medidur Clinical Trials 3 20/03/2006 10:00 Medidur Manufacture Certified to be GMP Equivalent to EU 2 17/03/2006 15:18 pSivida added to new Nantechnology Index 2 16/03/2006 20:40 Half Yearly Report/Half Year Accounts 31 16/03/2006 14:56 Response to ASX Query re: Share Price 4 02/03/2006 12:57 Change of Director's Interest Notice 2 23/02/2006 11:17 Change of Director's Interest Notice 2 22/02/2006 12:12 Change of Director's Interest Notice 2 21/02/2006 10:20 Diabetic Macular Edema trial with Retisert 3 21/02/2006 10:01 Uveitis long term trial results positive 2 10/02/2006 09:43 Novartis to Co-Promote Retisert With Bausch & Lomb 2 31/01/2006 15:55 pSivida Quarterly Cashflow Dec 2005 Commentary & Highlights 3 31/01/2006 15:53 Commitments Test Entity - Second Quarter Report 5 16/01/2006 17:25 Initial and Final Director's Interest Notices 4 12/01/2006 09:43 Non-executive Director Appointment 2 06/01/2006 16:21 Change of Director's Interest Notice x 2 5 05/01/2006 19:37 Initial Director's Interest Notice 2 05/01/2006 09:48 New Pharma Drug Delivery Evaluation Agreements-US Subs. 2 03/01/2006 12:03 pSivida Completes Acquisition of Control Delivery Systems 3 03/01/2006 09:51 Trading Halt 2 30/12/2005 15:08 Appendix 3B 10 23/12/2005 13:44 Information Statement on acquisition of CDS 189 13/12/2005 09:45 Open Briefing: Beijing Med-Pharm & General Update 8 06/12/2005 09:49 AION Diagnostics Develop Product Pipeline/Preclinical Trials 2 01/12/2005 13:12 Corr to Hdr: Launches pSiNutria in the Food Industry 2 01/12/2005 09:57 Launces pSiNutria in the Food Industry 2 28/11/2005 19:40 Response to ASX Share Price Query 3 18/11/2005 19:18 Final Director's Interest Notice 2 17/11/2005 20:18 Appendix 3B 9 16/11/2005 08:39 Recognised in Prestigious Business Awards 2 15/11/2005 15:42 Gavin Rezos presentation at pSivida AGM 36 15/11/2005 12:33 Results of Meeting 6 31/10/2005 18:24 Quarterly Cashflow Commentary & Highlights - September 2005 4 31/10/2005 18:21 Commitments Test Entity - First Quarter Report 5 31/10/2005 10:17 Commencement of Phase IIb Clinical Trials for BrachySil 3 27/10/2005 09:42 Beijing Med-Pharm Licence 2 26/10/2005 10:10 To ring closing on NASDAQ Stock Market 2 24/10/2005 13:09 To present at Lux Executive Summit in Cambridge MA 2 13/10/2005 20:08 2005 Annual Report
  23. s4rx7

    PVA

    Here is the refresher, and No I do not intend to continue to post on PSD. Posted on: Friday 20/10/06 01:44pm Replies: 13579 Views: 326914 In reply to: diana on Friday 20/10/06 12:39pm Hello Diana Can i ask why you still consider a big pharma deal is likely to be on the horizon? It appears to me that the evaluations that were announced by the company have not resulted in any of the Big Pharmas indicating their willingness to use Biosilicon as a drug delivery method or application. Infact I believe Biosilicon has not really progressed very far at all since 2001. Why did PSD make such a big deal about a clean room Bausch and Lomb is a different story altogether. Whats happened to AION? I am interested in obtaining every posters opinion on how they view Psividas prospects. The view I have formed is based mainly on the company's past performance history and a few rumours floating around. I am happy to be persuaded that Psivida is in fact oversold and has some potential in the short or medium term if anyone can produce some evidence that this could happen. My fear is that PSD could turn its toes up at any time, this looks alarmingly like the death rattles from where i sit in my gloomy hole. Hopefully this forum's discussion will clarify some issues about the real situation shareholders face. 13/10/2006 18:01 Notice of Annual General Meeting 8 10/10/2006 08:29 First Patient Implanted in European Pancreatic Cancer Study 2 29/09/2006 20:28 2006 Annual Report 103 27/09/2006 10:41 Completes Agreement to Secure Additional US$6.5m Funding 11 27/09/2006 10:38 Voluntary Lock-up Period Expires on Acquisition Shares 2 26/09/2006 18:37 Non-Executive Director Appointment 2 19/09/2006 18:55 Results of General Meeting 3 19/09/2006 12:34 Initiation of Phase II clinical study of new product 2 15/09/2006 10:44 Completes agreement with existing Note Holder 2 14/09/2006 08:29 Preliminary Final Report 17 13/09/2006 09:23 Retisert wins International Award 2 28/08/2006 17:56 Final Director's Interest Notice 2 28/08/2006 09:34 Non-exec Director resigns from Board 2 21/08/2006 18:15 Notice of Extraordinary General Meeting 18 31/07/2006 19:11 Final Director's Interest Notice 2 31/07/2006 09:57 Secures additional US$6.5m funding 2 31/07/2006 09:56 pSivida Management Changes 2 31/07/2006 09:52 Commentary re: Quarterly Report 6 31/07/2006 09:48 Commitments Test Entity - Fourth Quarter Report 5 17/07/2006 09:30 Amends subordinated convertible debentures 4 10/07/2006 17:42 To present at the NanoEquity Europe 2006 Conference 2 05/07/2006 09:41 BioSilicon Demonstrates Adjuvant Properties 2 30/06/2006 17:58 Voluntary Lock-Up Period Expires on Acquisition Shares 2 22/06/2006 16:51 pSivida to present at the London Biotech Investment Forum 2 14/06/2006 15:48 pSivida to present at the Wall Street Analyst Forum 2 14/06/2006 09:52 pSivida Rights Issue Closure 2 14/06/2006 09:38 Change of Director's Interest Notice 2 14/06/2006 09:37 Change of Director's Interest Notice 2 14/06/2006 09:37 Change of Director's Interest Notice 2 08/06/2006 09:56 BioSilicon Breakthrough 3 07/06/2006 09:54 Govt Approvals for International Phase 3 trials for Medidur 3 30/05/2006 14:29 Directors to take up Entitlements under the Rights Issue 2 30/05/2006 09:59 BrachySil Regulatory Approval for European Pancreatic Trial 2 25/05/2006 10:06 Expansion of BrachySil Liver Cancer Clinical Trial 2 24/05/2006 14:10 Despatch of Rights Issue Prospectus 2 23/05/2006 10:14 Appoints Boston Based CFO & General Counsel 2 11/05/2006 18:30 Prospectus for a Non-renounceable Rights Offer 69 02/05/2006 14:08 Appendix 3B Rights Issue 11 02/05/2006 13:39 Rights Issue to fund late stage Macular Edema trials 3 28/04/2006 13:54 Appendix 4C - Commentary & Highlights 4 28/04/2006 13:43 Commitments Test Entity - Third Quarter Report 5 21/04/2006 16:14 Appendix 3B - Exercise of Unlisted Options 7 21/04/2006 09:51 To present at UBS Conference in New York 2 06/04/2006 09:50 Positive European Trial Results for Retisert 2 05/04/2006 09:29 New evaluation agmt for cardiovascular drug delivery 2 03/04/2006 09:47 Retisert slows progression of Diabetic Retinopathy in trials 3 22/03/2006 09:36 Open Briefing: pSivida Update on Progress 6 21/03/2006 09:52 DSMB Recommends Continuation of Medidur Clinical Trials 3 20/03/2006 10:00 Medidur Manufacture Certified to be GMP Equivalent to EU 2 17/03/2006 15:18 pSivida added to new Nantechnology Index 2 16/03/2006 20:40 Half Yearly Report/Half Year Accounts 31 16/03/2006 14:56 Response to ASX Query re: Share Price 4 02/03/2006 12:57 Change of Director's Interest Notice 2 23/02/2006 11:17 Change of Director's Interest Notice 2 22/02/2006 12:12 Change of Director's Interest Notice 2 21/02/2006 10:20 Diabetic Macular Edema trial with Retisert 3 21/02/2006 10:01 Uveitis long term trial results positive 2 10/02/2006 09:43 Novartis to Co-Promote Retisert With Bausch & Lomb 2 31/01/2006 15:55 pSivida Quarterly Cashflow Dec 2005 Commentary & Highlights 3 31/01/2006 15:53 Commitments Test Entity - Second Quarter Report 5 16/01/2006 17:25 Initial and Final Director's Interest Notices 4 12/01/2006 09:43 Non-executive Director Appointment 2 06/01/2006 16:21 Change of Director's Interest Notice x 2 5 05/01/2006 19:37 Initial Director's Interest Notice 2 05/01/2006 09:48 New Pharma Drug Delivery Evaluation Agreements-US Subs. 2 03/01/2006 12:03 pSivida Completes Acquisition of Control Delivery Systems 3 03/01/2006 09:51 Trading Halt 2 30/12/2005 15:08 Appendix 3B 10 23/12/2005 13:44 Information Statement on acquisition of CDS 189 13/12/2005 09:45 Open Briefing: Beijing Med-Pharm & General Update 8 06/12/2005 09:49 AION Diagnostics Develop Product Pipeline/Preclinical Trials 2 01/12/2005 13:12 Corr to Hdr: Launches pSiNutria in the Food Industry 2 01/12/2005 09:57 Launces pSiNutria in the Food Industry 2 28/11/2005 19:40 Response to ASX Share Price Query 3 18/11/2005 19:18 Final Director's Interest Notice 2 17/11/2005 20:18 Appendix 3B 9 16/11/2005 08:39 Recognised in Prestigious Business Awards 2 15/11/2005 15:42 Gavin Rezos presentation at pSivida AGM 36 15/11/2005 12:33 Results of Meeting 6 31/10/2005 18:24 Quarterly Cashflow Commentary & Highlights - September 2005 4 31/10/2005 18:21 Commitments Test Entity - First Quarter Report 5 31/10/2005 10:17 Commencement of Phase IIb Clinical Trials for BrachySil 3 27/10/2005 09:42 Beijing Med-Pharm Licence 2 26/10/2005 10:10 To ring closing on NASDAQ Stock Market 2 24/10/2005 13:09 To present at Lux Executive Summit in Cambridge MA 2 13/10/2005 20:08 2005 Annual Report 76 13/10/2005 09:53 Open Briefing pSivida MD on CDS Acquisition 6 07/10/2005 18:50 Notice of Annual General Meeting 51 07/10/2005 10:26 Retisert approved for US Medicare rebate 3 06/10/2005 12:27 Secures additional US$15m funding 2 06/10/2005 09:58 Trading Halt 2 04/10/2005 14:19 CDS Launches Phase III Trial for Retinal Condition 3 04/10/2005 09:57 To acquire Control Delivery Systems 4 15/09/2005 10:10 Completes Manufacturing Infrastructure for BrachySil 2 13/09/2005 20:01 Full Year Accounts 58 13/09/2005 19:42 Preliminary Final Report 12 13/09/2005 16:40 To present at ThinkEquity Partners Conf in San Francisco 2 06/09/2005 16:05 Appendix 3B 9 06/09/2005 10:02 Collaboration with Cirrus Pharmaceuticals 2 24/08/2005 09:59 Closes ADR PIPE after raising US$4.2m 2 16/08/2005 17:01 Initial Director's Interest Notice x2 4 16/08/2005 09:38 5th US Patent Granted 2 15/08/2005 10:14 In negotiations regarding potential acquisition 2 15/08/2005 10:14 Reinstatement to Official Quotation 1 08/08/2005 09:37 Suspension from Official Quotation 2 03/08/2005 18:14 Trading Halt 2 29/07/2005 16:40 Quarterly Cashflow - Commentary 4 29/07/2005 16:40 Commitments Test Entity - Fourth Quarter Report 5 28/07/2005 15:29 Becomes founding member of NASDAQ Health Care Index 3 27/07/2005 09:50 Appoints CFO of Indevus as Non-Executive Director 2 26/07/2005 16:38 Notice of shares to be released from Escrow 2 26/07/2005 16:35 Appendix 3B - Escrow Release 8 25/07/2005 12:07 Appts CEO of Chugai Phama USA as Non-Executive Director 2 21/06/2005 16:38 BrachySil Cancer Therapy Achieves Primary Endpoint 4 20/06/2005 09:43 Initiates R&D Collaboration with University of S.A. 2 16/06/2005 09:35 First Korean Patent Granted 2 18/05/2005 09:35 EPT:EPT & PSD complete first stage of proof of concept study 4 18/05/2005 09:30 PSD & EPT successfully complete first stage of study 2 16/05/2005 11:31 Roche Diagnostics VP Joins AION Board 2 10/05/2005 09:50 Chinese Patent Granted 2 03/05/2005 09:48 BrachySil to be Presented at Annual ESTRO Conference 2 22/04/2005 16:23 Appendix 3B: Employee Share Option Plan 9 22/04/2005 09:41 Quarterly Cashflow Commentary & Highlights 3 22/04/2005 09:38 Commitments Test Entity - Third Quarter Report 5 12/04/2005 09:52 Top 5 global pharma update on drug delivery evaluation 2 08/04/2005 09:40 Expands market for lead cancer product BrachySil 2 04/04/2005 11:06 Webcast of Presentation Stephens Inc Nanotechnology Inv Conf 2 30/03/2005 11:43 Production Scale-up for BrachySil Cancer Therapy 2 17/03/2005 08:40 pSivida added to Merrill Lynch Nanotechnology Index 2 11/03/2005 11:41 Shareholder Update - March 2005 5 03/03/2005 15:25 Change of Director's Interest Notice 2 01/03/2005 10:30 Future Out-Licensing-fBioSilicon in Tissue Eng./Orthopedics 2 28/02/2005 19:05 Half Year Accounts & Half Year Accounts 16 17/02/2005 10:10 Open Briefing: Strategy Director on BrachySil Trial Results 8 15/02/2005 09:34 Positive Phase IIa Trial Results in Liver Cancer 3 02/02/2005 09:50 To Present at Brean Murray & Co. Annual Institutional Conf. 2 31/01/2005 15:39 December 2004 - Commentary & Highlights 3 31/01/2005 15:38 Commitments Test Entity - Second Quarter Report 5 27/01/2005 13:48 Webcast of Investor Meeting following NASDAQ Listing 1 25/01/2005 13:29 ADSs Slated to Commence Trading 3 20/01/2005 18:45 Shares to be released from escrow 2 20/01/2005 13:37 Planned NASDAQ Listing 2 10/01/2005 09:57 4th US Patent Granted 2 04/01/2005 08:30 Appendix 3B - conversion of unlisted options 8 22/12/2004 14:19 Open Briefing. Global Pharma. Agreement & ADR Listing 7 22/12/2004 12:32 Top 5 Pharma.to Evaluate BioSilicon for Drug Delivery 3 22/12/2004 09:33 Trading Halt 2 14/12/2004 19:52 Appendix 3B - Conversion of Unlisted Options 8 14/12/2004 19:28 Appendix 3B - Conversion of Unlisted Options 8 23/11/2004 09:31 Change of Director's Interest Notice x3 9 17/11/2004 19:57 Results of AGM 2 17/11/2004 09:47 Change of Director's Interest Notice 3 16/11/2004 10:23 Agreement with ITOCHU to Develop & Commercialize Products 2 11/11/2004 20:05 Appendix 3B - Conversion of unlisted options 8 03/11/2004 09:49 pSivida Appoints New R&D Director 2 29/10/2004 14:37 Quarterly Cash Flow - Commentary & Highlights 4 29/10/2004 14:37 Commitments Test Entity - First Quarter Report 5 19/10/2004 10:06 Letter to Shareholders 2 19/10/2004 10:05 Annual Report 60 18/10/2004 20:26 Notice of Annual General Meeting 12 13/10/2004 14:24 Presents at World Nano-Economic Congress Singapore 2 13/10/2004 09:36 New Euro Patent granted Dermatological Appl for BioSilicon 2 08/10/2004 17:03 Appendix 3B - Conversion of Unlisted Options 8 07/10/2004 09:44 Positive Interim Results for BrachySil Trial 3 30/09/2004 17:56 Full Year Accounts 35 23/09/2004 08:48 AION Diagnostics Limited 3 09/09/2004 17:26 5th European Patent Granted 2 08/09/2004 16:21 Appoints Additional German Maker Seydler AG 2 02/09/2004 17:19 European Patent Granted 2 30/08/2004 16:10 Commentary & Highlights - June 2004 Preliminary Final Report 5 30/08/2004 16:08 Preliminary Final Report 12 27/08/2004 16:52 Appendix 3B - Conversion of Unlisted Options 8 20/08/2004 17:06 App 3B - Conversion of Unlisted Options Expiring Dec 041 8 17/08/2004 15:20 Appendix 3B - Conversion of Unlisted Options 8 13/08/2004 15:49 Appendix 3B - Conversion of Unlisted options 8 09/08/2004 16:20 Becoming & Change in a substantial holder 4 06/08/2004 16:08 Change in sub holding x2/Becoming a sub holder 8 06/08/2004 11:32 Appendix 3B - Conversion of unlisted options 8 05/08/2004 13:13 Change of Director's Interest Notice x3 8 05/08/2004 09:10 pSiMedica Acq Completed/Appt of new Directors 2 05/08/2004 08:30 Appendix 3B - Acquisition of pSiMedica 9 04/08/2004 08:30 New US Patent Granted 2 02/08/2004 12:40 Final Director's Interest Notice 2 02/08/2004 12:40 Initial Director's Interest Notice x 2 4 30/07/2004 13:39 Results of General Meeting 5 30/07/2004 08:30 Quarterly Cash Flow - June 2004: Commentary & Highlights 3 30/07/2004 08:28 Disclosure Document 37 30/07/2004 08:28 Commitments Test Entity - Fourth Quarter Report 5 27/07/2004 09:46 New Patent Granted - BioSilicon Tablets 2 15/07/2004 09:47 Frost & Sullivan Excellence in Research Award 2 14/07/2004 15:39 Appendix 3B - Conversion of unlisted options 8 08/07/2004 15:23 FIRB Approval Received 2 01/07/2004 09:56 New Australian Patent Granted-BioSilicon Information Carrier 2 30/06/2004 12:48 Notice of General Meeting 43 30/06/2004 12:47 Letter to Shareholders re Update 3 15/06/2004 09:25 First patients receive BioSilicon 2 09/06/2004 09:41 Presentation at BIO 2004 2 08/06/2004 10:17 To Present at Medtech Insight Conference 2 07/06/2004 16:42 Admitted to Trading in the UK on OFEX Int. Market Service 3 02/06/2004 09:21 pSivida Acquires 100% of pSiMedica 3 01/06/2004 09:43 New European Patent Granted - Resorbable BioSilicon 2 25/05/2004 18:19 Appointment of New Company Secretary 2 21/05/2004 09:32 University of Pittsburgh Collaboration: DNA Vaccine Delivery 2 19/05/2004 18:35 Appendix 3B - Conversion of unlisted options 8 18/05/2004 09:39 7th World Biomaterials Congress - BioSilicon Presentation 2 12/05/2004 14:17 Second Commercial Manufacturing Agreement for BrachySil 2 10/05/2004 12:39 pSiMedica Extends Ownership of pSiOncology 3 03/05/2004 16:44 Appendix 3B - Conversion of Unlisted Options exp 31-Dec-04 7 30/04/2004 15:38 March 2004 Commentary & Highlights 3 30/04/2004 15:35 Commitments Test Entity - Third Quarter Report 5 27/04/2004 10:17 Final regulatory approval obtained for BrachySil Trial 2 23/04/2004 16:47 Compliance Statement under ASIC Class Orders 02/1180&03/185 1 23/04/2004 16:27 Appendix 3B - R&D & Commercialisation of activities 7 22/04/2004 14:30 Compliance Statement Under ASIC Class Orders02/1180 & 03/185 1 22/04/2004 09:46 Additional A$6.5 M Placement to European Funds 2 20/04/2004 18:48 Appendix 3B - New Issue 9 19/04/2004 18:25 Notice re: Amended Constitution 1 19/04/2004 18:06 Amended Constitution 59 15/04/2004 09:48 $21M Placement to US & European Institutions 2 13/04/2004 10:01 Trading Halt 2 07/04/2004 13:22 Results of Meeting 2 06/04/2004 10:01 Final Pre-Clinical Milestone Attained for BrachySil 3 18/03/2004 16:11 Commerical Manufacturing Agreement 3 15/03/2004 10:02 Important New European Patent -Derivatized BioSilicon 2 08/03/2004 15:59 Notice of General Meeting 10 08/03/2004 15:58 Shareholder Update 2 05/03/2004 08:54 S&P's announces Quarterly Rebalance to S&P/ASX Indices 3 27/02/2004 14:34 Half Year Audit Review 1 27/02/2004 14:34 Half Yearly Report/Half Year Accounts 12 26/02/2004 16:12 New US Collaboration in Nanotechnology 2 04/02/2004 16:50 Appendix 3B - Conversion of Unlisted Options 7 30/01/2004 14:52 Quarterly Cash Flow - December 2003 Commentry & Highlights 2 30/01/2004 14:52 Commitments Test Entity - Second Quarter Report 5 23/01/2004 17:27 Response to ASX Query re:Share Price 4 21/01/2004 17:37 US Patent Granted for BioSilicon Smart Drug Delivery 2 20/01/2004 18:19 Change of Director's Interest Notice x4 8 14/01/2004 18:14 Secure additional German Listings 2 07/01/2004 18:02 Appendix 3B:Conversion of unlisted options expiring 31/12/04 7 07/01/2004 17:49 Diagnostics Business Strategy 3 24/12/2003 08:31 Appendix 3B - conversion of unlisted options 7 19/12/2003 09:58 Scientific Update - BioSilicon 2 28/11/2003 17:21 Appendix 3B - Employee Share Option Plan 7 24/11/2003 18:35 Licensing Agreement - Porous Silicon Mirror Technology 2 24/11/2003 17:40 Change of Director's Interest Notice 3 18/11/2003 11:56 Commercial Director Appointed 2 30/10/2003 09:47 Commitments Test Entity - First Quarter Report 5 30/10/2003 09:47 Quarterly Cash Flow - Commentary & Highlights 3 27/10/2003 14:07 Lists on the Frankfurt Stock Exchange 2 22/10/2003 09:45 Flinders Uni Collaboration Supported-Aus Research Council 2 21/10/2003 19:30 Results of Annual General Meeting 3 06/10/2003 14:58 Appendix 3B - to increase shareholding pSiMedica 7 03/10/2003 16:44 Appendix 3B - Conversion of unlisted options 7 03/10/2003 14:58 Compliance Statement under ASIC Class Orders 02/1180&03/185 2 03/10/2003 11:03 pSivida to own Diagnostics Platform using BioSilicon 2 03/10/2003 09:22 $6.5M Capital Raising Closes Heavily Oversubscribed 2 30/09/2003 18:41 Trading Halt 2 30/09/2003 13:48 Important New US Patent for BioSilicon - Smart Applications 2 24/09/2003 09:53 Epitan To Develop Melanotan Products using BioSilicon 2 24/09/2003 09:22 EPT's ann: Colaboration with pSiMedica Limited 2 19/09/2003 16:28 Notice of Annual General Meeting 4 19/09/2003 16:22 2003 Annual Report 48 12/09/2003 14:30 Preliminary Final Report - June 2003 Commentary & Highlights 3 12/09/2003 14:29 Preliminary Final Report 12 11/09/2003 09:18 Major milestone in first BioSilicon cancer product 3 09/09/2003 09:59 UK broker appointed to list pSiMedica 2 08/09/2003 17:14 Appendix 3B - Conversion of Unlisted Options 7 28/08/2003 17:25 Appendix 3B - Conversion of Unlisted Options 7 27/08/2003 17:30 Appendix 3B - Conversion of Unlisted Options 7 20/08/2003 17:51 Appendix 3B - Conversion of Unlisted Options 7 19/08/2003 12:02 BioSilicon to be evaluated for C3 prod through McComb Found 2 14/08/2003 14:16 pSivida to present at AusBiotech 2003 2 05/08/2003 11:29 Change of Director's Interest Notice 2 05/08/2003 11:28 Change of Director's Interest Notice 2 04/08/2003 17:48 Appendix 3B - Share Purchase Plan 8 04/08/2003 13:34 Change of Director's Interest Notice 2 04/08/2003 13:32 Change of Director's Interest Notice 2 04/08/2003 13:25 Appendix 3B - Share Purchase Plan 7 31/07/2003 17:19 Quarterly Cash Flow June 2003 - Commentary & Highlights 2 31/07/2003 17:19 Commitments Test Entity - Fourth Quarter Report 5 30/07/2003 14:20 Approx $900000 raised under Share Purchase Plan 1 30/07/2003 13:27 New Singapore General Hospital Collaboration 2 18/07/2003 10:08 Cytomatrix - Cell Research Agreement 2 30/06/2003 16:39 Shaer Purchase Plan 4 19/06/2003 13:12 Appendix 3B - Conversion of unlisted options 7 19/06/2003 13:03 Share Purchase Plan 4 18/06/2003 09:56 Revenue Sharing Agmt with Texas Christian University 3 19/05/2003 16:25 Change of Director's Interest Notice 2 19/05/2003 16:24 Appendix 3B - End of Restriction Period 7 06/05/2003 17:36 Release of Restricted Securities 1 06/05/2003 10:06 Top US Nano-Silicon Expert Collaboration 2 29/04/2003 16:16 Commitments Test Entity - Third Quarter Report 5 29/04/2003 16:13 Commentary & Highlights re:Quarterly Cash Flow March 2003 2 15/04/2003 09:22 Further important patent granted for Biosilicon in Australia 2 01/04/2003 09:49 First Patent Granted for Biosilicon in Australia 2 11/03/2003 12:55 Management Commentary - Half Year Result 2 11/03/2003 12:54 Half Yearly Report & Half Year Accounts 24 06/03/2003 14:30 Shareholder Letter March 2003 2 04/02/2003 09:45 Collaboration with Birmingham University UK 2 31/01/2003 15:11 Commitments Test Entity - Second Quarter Report 5 30/01/2003 09:41 To present at the World Nanotechnology Summit 2 09/01/2003 17:06 Initial Director's Interest Notice 2 07/01/2003 09:55 Director Appointment 1 10/12/2002 09:56 Carlyle Group acquies 34% Stake in QinetiQ 2 06/12/2002 12:08 Appendix 3B - Employee Share Option plan 7 25/11/2002 10:11 Change of Director's Interest Notice 2 25/11/2002 09:49 Appendix 3B - Issue to Director 8 19/11/2002 12:44 Response to ASX Query re Share Price 4 13/11/2002 20:06 Change of Registered office & Principal Place of Business 1 11/11/2002 10:21 Change of Director's Interest Notice 2 01/11/2002 14:26 Results of Meeting 2 31/10/2002 13:38 Commitments Test Entity - First Quarter Report 5 31/10/2002 13:37 Quarterly Cash Flow - September 2002 2 10/10/2002 19:20 Disclosure Document re: Placement 1 10/10/2002 16:32 Appendix 3B - Working Capital 8 10/10/2002 12:11 Raises $840000 via placement 2 09/10/2002 09:52 New Biosilicon Diagnostic Skin Patch Device 2 04/10/2002 11:59 Change of Director's Interest Notice 2 02/10/2002 14:28 Change of Director's Interest Notice 2 01/10/2002 19:26 Notice of Annual General Meeting 8 01/10/2002 19:13 Annual Report/Top 20 23 01/10/2002 18:10 Change of Director's Interest Notice 2 24/09/2002 09:52 New European Patent Granted for Biosilicon 2 17/09/2002 17:40 Appendix 3B - New Issue 8 17/09/2002 10:12 Signs A$7.5M Equity Line of Credit Agreement 3 13/09/2002 15:42 Preliminary Final Report 20 13/09/2002 14:59 Management Commentary to Appendix 4B Preliminary Report 2 30/07/2002 11:19 Cancer Therapy JV with Singapore General Hospital 4 29/07/2002 16:50 Commitments Test Entity - Fourth Quarter Report 5 22/07/2002 10:57 New Collaborative Agree.signed with UK-BIO Pharmaceutical Co 1 27/06/2002 10:26 Highlighted by Asia Pacific Science Summit 1 11/06/2002 08:57 Materials Transfer Agreement with US Based Orthopaedics Coy 2 04/06/2002 11:27 Bio2002 Powerpoint Investor Presentation 1 23/05/2002 11:06 Change of Director's Interest Notice 2 17/05/2002 09:07 Change of Director's Interest Notice 2 10/05/2002 12:36 Appendix 3B - End of Restriction Period 7 09/05/2002 12:25 Change of Director's Interest Notice 2 09/05/2002 12:24 Appendix 3B - Share Purchase Plan 8 09/05/2002 11:47 Share Purchase Plan-approx 1m shares issued at 22c 1 30/04/2002 09:52 Notice of Allowance for Biosilicon Patent Received in the US 2 29/04/2002 16:12 Notice of shares to be released from escrow 1 29/04/2002 10:10 UK Subsidiary - Progress in Drug Delivery Program 2 26/04/2002 11:39 Quarterly Cash Flow-March 2002 Management Commentary 2 26/04/2002 11:39 Commitments Test Entity - Third Quarter Report 5 18/04/2002 10:54 Change of Director's Interest Notice 2 17/04/2002 12:04 Change of Director's Interest Notice 2 09/04/2002 10:46 Letter to Shareholders - Share Purchase Plan 3 05/04/2002 12:53 Results of Meeting 1 03/04/2002 10:13 High profile US executive apppointed to PsiMedica Board 2 28/03/2002 12:50 Share Purchase Plan 2 12/03/2002 10:09 pSivida Increases Ownership in UK Subsidiary 2 11/03/2002 10:02 PSD & Medtronic co-sponsor World Porous Silicon Conference 3 08/03/2002 08:36 Initial & Final Director`s Interest Notices 5 06/03/2002 10:09 Letter to Shareholders re Company Update 2 05/03/2002 09:54 Former SmithKline & French Research Chief To Chair pSvida 3 04/03/2002 10:14 Notice of General Meeting 4 22/02/2002 10:29 Half Yearly Report & ASIC Half Yearly Accounts 22 31/01/2002 12:02 Commitments Test Entity - Second Quarter Report 5 29/01/2002 14:19 pSivida Subsidiary in New Biosilicon Collaboration 3 08/01/2002 18:43 Initial Director`s Interest Notice x3 6 21/12/2001 18:52 Section 205G Notice - Director`s Interests 2 21/12/2001 18:31 Section 205G Notice - Director`s Interests 2 20/12/2001 12:56 Appendix 3B - Employee share option plan 7 13/12/2001 09:59 Intellectual property broadened with new US agreement 2 05/12/2001 12:38 Change in substantial holding x2 7 05/12/2001 08:32 Ceasing to be a substantial holder 2 03/12/2001 10:00 US Patent Granted for Biosilicon Implants in Drug Delivery 2 22/11/2001 15:59 Appendix 3B - Placement 7 22/11/2001 15:58 Raises $2.4M via Placement 1 13/11/2001 17:27 Media Release re: 2001 Annual Report 1 01/11/2001 20:30 Results of Annual General Meeting 2 29/10/2001 12:34 Section 205G Notice - Director`s Interests 2 29/10/2001 12:31 Commitments Test Entity - First Quarter Report 5 24/10/2001 08:30 Key Scientific&Commercial Appointments to Advance Biosilicon 1 23/10/2001 10:13 Notice of Annual General Meeting/Rules of Emp. Share Plan 36 23/10/2001 09:49 Annual Report/Top20 44 22/10/2001 19:37 Terms & Conditions - Issue of Options to Dr Brimblecombe 3 22/10/2001 16:26 Change in substantial holding 2 22/10/2001 15:09 Annual Report & Top 20 rec`d (full copy not yet available) 1 22/10/2001 14:23 Notice of AGM & Amendment on Terms of ESOP 35 19/10/2001 15:00 Terms & Conditions of Employee Share Option Plan 1 17/10/2001 11:02 Biotechnology Seminar International Exec`s to attend&present 1 16/10/2001 18:35 Section 205G Notice - Director`s Interests 2 16/10/2001 10:33 In Second Collaboration with PowderJect plc 2 27/09/2001 17:41 Annual Report/Top 20 23 12/09/2001 18:24 Preliminary Final Report 18 09/08/2001 11:17 Significant Progress for Collaboration on Osteoporosis 2 30/07/2001 13:14 Commitments Test Entity - Fourth Quarter Report 6 24/07/2001 09:30 Sells Residual Property Asset 3 22/06/2001 14:23 Section 205G Notice - Director`s Interests 3 07/06/2001 16:00 Section 205G Notice - Director`s Interes 1/1 (P) 1 07/06/2001 15:36 Section 205G Notice - Director's Interests 3 24/05/2001 10:53 Change in substantial holding 1/1 (P) 1 23/05/2001 19:28 Change in substantial holding 1/1 (P) 1 23/05/2001 18:55 Change in substantial holding 3 18/05/2001 11:22 Change of Registered office address 1/1 (P) 1 18/05/2001 10:43 Change of Registered office address 1 18/05/2001 10:20 New Biotechnology group makes debut on A 1/1 (P) 1 18/05/2001 09:32 New Biotechnology group makes debut on ASX 3 17/05/2001 14:53 Page 18 - Information Memorandum (ann.17 1/1 (P) 1 17/05/2001 14:32 Information Memorandum 3/4 (P) 1 17/05/2001 14:30 Information Memorandum 4/4 (P) 1 17/05/2001 14:20 Reinstatement to Official Quotation 18/5 1/1 (P) 1 17/05/2001 14:10 Information Memorandum 2/4 (P) 1 17/05/2001 14:00 Reinstatement to Official Quotation 18/5/2001 3 17/05/2001 13:59 Information Memorandum 1/4 (P) 1 17/05/2001 13:04 Page 18 - Information Memorandum (ann.17/5/01) 2 17/05/2001 11:37 Information Memorandum 104 16/05/2001 10:09 Top 20 shareholders 1/1 (P) 1 16/05/2001 10:00 Pre-Quotation Disclosure 2/2 (P) 1 16/05/2001 09:55 Number & Escrow Period of Restricted Sec 1/1 (P) 1 16/05/2001 09:47 Pre-Quotation Disclosure 1/2 (P) 1 16/05/2001 09:42 Number & Escrow Period of Restricted Securities 1 16/05/2001 09:42 Top 20 shareholders 3 16/05/2001 09:39 Pre-Quotation Disclosure
  24. s4rx7

    PVA

    In reply to: Pessimist on Wednesday 11/04/07 09:53am Gday Pess "I'm amazed by the continuing weakness in the SP. It's as though the deal is worthless." In my opinion..........It is!! and long term holders have all been had yet again. At the time I voiced my strong opinion many months ago, posters at the time called me the snake for exiting at .50, but the shareprice subsequently succumbed to the real poison. perhaps Astoria could enlighten us all regarding his day job........hrmmm As I predicted Pess, the misery continues for holders. Traders "in the know" will continue to selectively pick at the carcass. Unfortunately from what i have discovered, there is no rosy future for some biotechs with promising technology. Hands up who really believes PSD has a future ?? My guess is only the manipulators will respond. Its the genuine people that come onto this board to tell it like it is. A long time ago i got sucked in, but somewhere along the way the WAKE UP BUTTON got pushed. The purpose of my post ?? Selling out of PSD was difficult for me, but fortunately it was the best move , Ive no regrets, as i learned a lot from the sharks and even though PSD was an obvious pump and dump situation recently I refrained from entering because of my basic principles. lastly,regarding the "NEW and IMPROVED MANAGEMENT" current scorecard so far in restoring shareholders wealth, A BIG FAT ZERO cheers all
  25. s4rx7

    RRS

    Blaze It appears from reading your prior postings on this board that you tend to see the negative view of RRS. You may well be correct, however I have reason to believe otherwise. Always good to hear both sides of any story. Wilson's buying is one reason to be hopeful of a good outcome in my view. It will be interesting to watch events transpire over the coming months. By June 2007 I expect we should have a good grasp of who is at the helm in Puntland and if we are to have a happy ending.
×
×
  • Create New...